Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Find generic entry opportunities
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Phenyl heterocycles as cox-2 inhibitors|
|Abstract:||The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases, ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.|
|Inventor(s):||Ducharme; Yves (Montreal, CA), Gauthier; Jacques Y. (Laval, CA), Prasit; Petpiboon (Kirkland, CA), Leblanc; Yves (Kirkland, CA), Wang; Zhaoyin (Pierrefond, CA), Leger; Serge (Dollard Des Ormeaux, CA), Therien; Michel (Laval, CA)|
|Assignee:||Merck Frosst Canada, Inc. (Kirkland, CA)|
Patent Claim Types:|
see list of patent claims
|Compound; Use; Composition;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||165825||<disabled in preview>|
|Austria||212343||<disabled in preview>|
|Australia||1269495||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.